Evidence map›Paper›PMID 34640562›Full record

ArticleJournal of clinical medicine2021

Prognosis of Laboratory-Confirmed Influenza and Respiratory Syncytial Virus in Acute Heart Failure.

David Carballo, Nicolas Garin, Jérôme Stirnemann, Aline Mamin, Virginie Prendki, Philippe Meyer, Christophe Marti, Francois Mach, Jean-Luc Reny, Jacques Serratrice and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

David CarballoService of Cardiology, Department of Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.ORCID 0000-0003-3212-1272
Nicolas GarinService of General Internal Medicine, Department of Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.
Jérôme StirnemannService of General Internal Medicine, Department of Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.ORCID 0000-0001-9964-4452
Aline MaminService of Infectious Diseases, Department of Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.
Virginie PrendkiService of Infectious Diseases, Department of Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.
Philippe MeyerService of Cardiology, Department of Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.
Christophe MartiService of General Internal Medicine, Department of Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.
Francois MachService of Cardiology, Department of Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.
Jean-Luc RenyService of General Internal Medicine, Department of Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.
Jacques SerratriceService of General Internal Medicine, Department of Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.
Laurent KaiserService of Infectious Diseases, Department of Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.
Sebastian CarballoService of General Internal Medicine, Department of Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.
University Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Concomitant respiratory viral infections may influence clinical outcomes of acute decompensated heart failure (ADHF) but this association is based on indirect observation. The aim of this study was to evaluate the prevalence and impact of laboratory-confirmed influenza or respiratory syncytial virus (RSV) infection on outcomes in patients hospitalised for ADHF. Prospective cohort of patients hospitalised for ADHF with systematic influenza and RSV screening using real-time PCR on nasopharyngeal swabs. The primary outcome was all-cause mortality or readmission at 90 days. Among 803 patients with ADHF, 196 (24.5%) patients had concomitant flu-like symptoms of influenza. PCR was positive in 45 patients (27 for influenza, 19 for RSV). At 90 days, PCR positive patients had lower rates of all-cause mortality or readmission as compared to patients without flu-like symptoms (HR 0.40, 95% CI 0.18-0.91,

Indexed as

acute heart failureinfluenzaRSV

Identifiers

PMID34640562
PMCPMC8509592
OpenAlexW3204469645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.